Redhill Biopharma Ltd. (RDHL)

Last Closing Price: 0.50 (2022-09-26)

Company Description

RedHill Biopharma Ltd. is a specialty biopharmaceutical company, focused on gastrointestinal and infectious diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment is based in Raleigh, NC, and covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded in 2009 and is headquartered in Tel Aviv, Israel.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $85.76M
Net Income (Most Recent Fiscal Year) $-97.74M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 0.32
Price to Book Ratio (Most Recent Quarterly Book Value per Share) --
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -110.31%
Net Margin (Trailing 12 Months) -110.31%
Return on Equity (Trailing 12 Months) -822.29%
Return on Assets (Trailing 12 Months) -49.86%
Current Ratio (Most Recent Fiscal Quarter) 0.98
Quick Ratio (Most Recent Fiscal Quarter) 0.79
Debt to Common Equity (Most Recent Fiscal Quarter) 9.42
Inventory Turnover (Trailing 12 Months) 3.70
Book Value per Share (Most Recent Fiscal Quarter) $0.17
Earnings per Share (Most Recent Fiscal Quarter) $-0.30
Earnings per Share (Most Recent Fiscal Year) $-2.10
Diluted Earnings per Share (Trailing 12 Months) $-1.88
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Common Shares Outstanding 52.68M
Free Float 49.10M
Market Capitalization $26.52M
Average Volume (Last 20 Days) 1.45M
Beta (Past 60 Months) 1.80
Percentage Held By Insiders (Latest Annual Proxy Report) 6.81%
Percentage Held By Institutions (Latest 13F Reports) 7.74%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%